These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2499137)

  • 1. [Comment on H. Wilken: Current problems of blood group incompatibility in pregnancy, Zent.bl. Gynäkol. 110 (1988) 1-11].
    Lahmann N
    Zentralbl Gynakol; 1989; 111(6):385-7. PubMed ID: 2499137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Response to the comment by N. Lahmann on "Current problems of blood group incompatibility in pregnancy"].
    Wilken H
    Zentralbl Gynakol; 1989; 111(6):388-9. PubMed ID: 2499138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R; Menzel K
    Z Arztl Fortbild (Jena); 1986; 80(4):143-8. PubMed ID: 3087070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is rhesus prophylaxis indicated also with positive antibodies?].
    Behrens O
    Z Geburtshilfe Neonatol; 1996; 200(6):246. PubMed ID: 9081755
    [No Abstract]   [Full Text] [Related]  

  • 5. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 8. Economics of anti-rhesus prophylaxis in an African population.
    Verkuyl DA
    Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 10. [Perinatal hemolytic disease caused by Rh incompatibility as a true social scourge. Interview between "Minerva Medica" and Professor Franco Gasparri].
    Barraciu A
    Minerva Med; 1970 Dec; 61(102 Suppl):5-8. PubMed ID: 5497702
    [No Abstract]   [Full Text] [Related]  

  • 11. [15 years of Rh-immunization prevention program].
    Eklund J; Nevanlinna HR
    Katilolehti; 1984; 89(8):284-7. PubMed ID: 6441856
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on manifestations of Rh-related hemolytic disease of the newborn in the years 1974-1989 in the Erfurt district].
    Töpke B; Menzel K; Uhlig R; Pfister U
    Kinderarztl Prax; 1991 Apr; 59(4):111-6. PubMed ID: 1905365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 15. Rh disease.
    Fleisher AA
    J Perinatol; 1989 Jun; 9(2):224-8. PubMed ID: 2500504
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rhesus prophylaxis--history and current status].
    Behrens O; Lellé RJ
    Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 20. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.